Long Noncoding RNAs as Biomarkers in Cancer
Long noncoding RNAs (lncRNAs) are a relatively well-characterized class of noncoding RNA (ncRNA) molecules, involved in the regulation of various cell processes, including transcription, intracellular trafficking, and chromosome remodeling. Their deregulation has been associated with the development and progression of various cancer types, the fact which makes them suitable as biomarkers for cancer diagnosis and prognosis. In recent years, detection of cancer-associated lncRNAs in body fluids of cancer patients has proven itself as an especially valuable method to effectively diagnose cancer. Cancer diagnosis and prognosis employing circulating lncRNAs are preferential when compared to classical biopsies of tumor tissues, especially due to their noninvasiveness, and have great potential for routine usage in clinical practice. Thus, this review focuses on summarizing the perspectives of lncRNAs as biomarkers in cancer, based on evaluating their expression profiles determined in body fluids of cancer patients.
Citations by journals
2
4
6
8
10
12
14
|
|
International Journal of Molecular Sciences
|
International Journal of Molecular Sciences
14 publications, 5.09%
|
Frontiers in Oncology
|
Frontiers in Oncology
11 publications, 4%
|
Cancers
|
Cancers
9 publications, 3.27%
|
Journal of Cellular Physiology
|
Journal of Cellular Physiology
8 publications, 2.91%
|
Molecular Medicine Reports
|
Molecular Medicine Reports
6 publications, 2.18%
|
Non-coding RNA
|
Non-coding RNA
6 publications, 2.18%
|
Frontiers in Genetics
|
Frontiers in Genetics
6 publications, 2.18%
|
Scientific Reports
|
Scientific Reports
5 publications, 1.82%
|
Cell Death and Disease
|
Cell Death and Disease
5 publications, 1.82%
|
Journal of Cellular Biochemistry
|
Journal of Cellular Biochemistry
5 publications, 1.82%
|
Oncology Letters
|
Oncology Letters
4 publications, 1.45%
|
Biochemical and Biophysical Research Communications
|
Biochemical and Biophysical Research Communications
4 publications, 1.45%
|
Biomedicines
|
Biomedicines
3 publications, 1.09%
|
Molecular Biology Reports
|
Molecular Biology Reports
3 publications, 1.09%
|
Cancer Letters
|
Cancer Letters
3 publications, 1.09%
|
Gene
|
Gene
3 publications, 1.09%
|
Biomedicine and Pharmacotherapy
|
Biomedicine and Pharmacotherapy
3 publications, 1.09%
|
Life Sciences
|
Life Sciences
3 publications, 1.09%
|
Journal of Cellular and Molecular Medicine
|
Journal of Cellular and Molecular Medicine
3 publications, 1.09%
|
Advances in Experimental Medicine and Biology
|
Advances in Experimental Medicine and Biology
3 publications, 1.09%
|
Disease Markers
|
Disease Markers
3 publications, 1.09%
|
BioMed Research International
|
BioMed Research International
3 publications, 1.09%
|
Translational Cancer Research
|
Translational Cancer Research
3 publications, 1.09%
|
Current Medicinal Chemistry
|
Current Medicinal Chemistry
2 publications, 0.73%
|
Genetic Testing and Molecular Biomarkers
|
Genetic Testing and Molecular Biomarkers
2 publications, 0.73%
|
Bioscience Reports
|
Bioscience Reports
2 publications, 0.73%
|
Experimental and Therapeutic Medicine
|
Experimental and Therapeutic Medicine
2 publications, 0.73%
|
International Journal of Oncology
|
International Journal of Oncology
2 publications, 0.73%
|
Medicine (United States)
|
Medicine (United States)
2 publications, 0.73%
|
2
4
6
8
10
12
14
|
Citations by publishers
10
20
30
40
50
|
|
Springer Nature
|
Springer Nature
50 publications, 18.18%
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
39 publications, 14.18%
|
Elsevier
|
Elsevier
36 publications, 13.09%
|
Wiley
|
Wiley
29 publications, 10.55%
|
Frontiers Media S.A.
|
Frontiers Media S.A.
26 publications, 9.45%
|
Spandidos Publications
|
Spandidos Publications
14 publications, 5.09%
|
Taylor & Francis
|
Taylor & Francis
12 publications, 4.36%
|
Hindawi Limited
|
Hindawi Limited
7 publications, 2.55%
|
AME Publishing Company
|
AME Publishing Company
5 publications, 1.82%
|
Royal Society of Chemistry (RSC)
|
Royal Society of Chemistry (RSC)
4 publications, 1.45%
|
Bentham Science
|
Bentham Science
3 publications, 1.09%
|
Wolters Kluwer Health
|
Wolters Kluwer Health
3 publications, 1.09%
|
American Chemical Society (ACS)
|
American Chemical Society (ACS)
3 publications, 1.09%
|
Pleiades Publishing
|
Pleiades Publishing
2 publications, 0.73%
|
IOS Press
|
IOS Press
2 publications, 0.73%
|
Mary Ann Liebert
|
Mary Ann Liebert
2 publications, 0.73%
|
Portland Press
|
Portland Press
2 publications, 0.73%
|
KeAi Communications Co.
|
KeAi Communications Co.
2 publications, 0.73%
|
Dove Medical Press
|
Dove Medical Press
2 publications, 0.73%
|
Oxford University Press
|
Oxford University Press
2 publications, 0.73%
|
Association for Computing Machinery (ACM)
|
Association for Computing Machinery (ACM)
1 publication, 0.36%
|
F1000 Research
|
F1000 Research
1 publication, 0.36%
|
Future Medicine
|
Future Medicine
1 publication, 0.36%
|
Impact Journals
|
Impact Journals
1 publication, 0.36%
|
S. Karger AG
|
S. Karger AG
1 publication, 0.36%
|
PeerJ
|
PeerJ
1 publication, 0.36%
|
Baishideng Publishing Group
|
Baishideng Publishing Group
1 publication, 0.36%
|
The Korean Society of Genetics
|
The Korean Society of Genetics, 1, 0.36%
The Korean Society of Genetics
1 publication, 0.36%
|
Neoplasia Press
|
Neoplasia Press, 1, 0.36%
Neoplasia Press
1 publication, 0.36%
|
10
20
30
40
50
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.